Continuing the success of UAC I, we launched Union Acquisition Corp. II completing its IPO on October 22, 2019 on the NASDAQ Stock Exchange. On March 31, 2021, UAC II announced a definitive business combination agreement along with a fully committed and oversubscribed PIPE financing agreement with Procaps Group. Post business combination, the newly formed company’s ordinary shares are expected to be listed on the Nasdaq Capital Market under the ticker symbol “PROC.”
Procaps Group is a leading global pharmaceutical technology and healthcare company based in Latin America and is well positioned to drive regional and global consolidation.
Procaps Group today is the largest pharmaceutical contract development and manufacturing organization “CDMO” in Latin America and top 3 globally in terms of volume of softgel production capacity.
The company’s state-of-the-art manufacturing capabilities provide innovative delivery technologies protected by an extensive IP moat and supported by industry accolades such as the first FDA-approved pharmaceutical plant in South America for selling Rx products into the U.S.